Journal
DERMATOLOGY
Volume 211, Issue 3, Pages 209-217Publisher
KARGER
DOI: 10.1159/000087013
Keywords
biological therapy; cutaneous adverse events; psoriasis
Categories
Ask authors/readers for more resources
The use of biological agents is expanding worldwide as a new treatment alternative for chronic inflammatory diseases including more recently skin diseases, especially psoriasis. Although frequently observed, the knowledge about acute and chronic dermatological adverse events is limited, and potential pathogenic mechanisms still have to be identified. Exact diagnosis is required considering that dermatological adverse events raise a decisional challenge about potential treatment discontinuation. The object of this publication is to present an overview of the dermatological adverse events of these new treatment alternatives.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available